Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects

Clinical trial NCT04636983 · COMPLETED

Trial details

NCT number: NCT04636983
Sponsor: BioVersys SAS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2020-11-09
Primary completion: 2021-12-12
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.